Position
Navalign, LLC in Thermo Fisher Scientific Inc.
Back to the book · All holders of TMO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$202.4K$579.38 → $491.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.3K | $1.33M | — | — | — | 0.3% |
| Q1 2026 | 2.38K | $1.17M | $491.47 | −$202.4K | $40.8K | 0.3% |